You are here

Article metrics

Article menu
Clinical/translational cancer immunotherapy
Original research
Phase II study of ceralasertib (AZD6738) in combination with durvalumab in patients with advanced gastric cancer

 

Online download statistics by month:

Online download statistics by month: July 2022 to March 2026

AbstractFullPdf
Jul 202210121030390
Aug 2022528542178
Sep 2022362369305
Oct 2022370380137
Nov 2022270272136
Dec 202221321393
Jan 202321922064
Feb 2023254256117
Mar 202325025493
Apr 202320120566
May 202319520295
Jun 202322122675
Jul 202325225270
Aug 202325225265
Sep 202325426064
Oct 202332533087
Nov 2023319321108
Dec 2023329337112
Jan 2024136137140
Feb 202417918370
Mar 2024459463256
Apr 202435735893
May 202414314353
Jun 202415415456
Jul 202431131175
Aug 202429629453
Sep 2024355355316
Oct 2024269270187
Nov 202428528879
Dec 202429930863
Jan 2025226229120
Feb 202530230385
Mar 202520320673
Apr 202520821070
May 202519419990
Jun 202513513550
Jul 2025110
Mar 2026110
Total10339104694184